Planned maintenance may cause outages to the Department of Health and Aged Care’s network from 5:15 pm AEDT on 30 November to 10:00 pm AEDT on 1 December 2024. Access to TGA databases such as TBS Portal, ARTG and DAEN may be affected. We apologise for any inconvenience.
RIXVYDA rituximab (rch) 500 mg/50 mL concentrated injection vial, Sandoz Pty Ltd, CON-298
Product name
RIXVYDA rituximab (rch) 500 mg/50 mL concentrated injection vial
Sponsor name
Sandoz Pty Ltd
ARTG
309668
Consent start
Consent no.
CON-298
Standard
Paragraph 8(1)(n) of Therapeutic Goods Order No 91-Standard for labels of prescription and related medicines.
Non-compliance with standard
The vial labels do not include a machine readable code which complies with that
defined in Therapeutic Goods Order No 91 - Standard for labels of prescription
and related medicines.
Conditions imposed
This consent applies only toRIXVYDA rituximab (rch) concentrated injection vial
containing 100mg/10mLRIXVYDA rituximab (rch) concentrated injection vial
containing 500mg/50mLRIXONFYA rituximab (rch) concentrated injection vial
containing 100mg/10mLRIXONFYA rituximab (rch) concentrated injection vial
containing 500mg/50mL
Therapeutic product type
Prescription medicines